GenSight Biologics S.A. (SIGHT.PA)
EUR 0.29
(-3.52%)
EUR 0.29
(-3.52%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.26 Million | 2.58 Million | 5.27 Million | 4.39 Million | 700 Thousand | 4.34 Million |
| Cost of Revenue | -1.73 Million | - | - | - | - | 315 Thousand |
| Gross Profit | 3 Million | 2.58 Million | 5.27 Million | 4.39 Million | 700 Thousand | 4.03 Million |
| Operating Expenses | 32.66 Million | 30.41 Million | 33.4 Million | 29.32 Million | 30.99 Million | 33.04 Million |
| Selling, General and Administrative Expenses | 7.26 Million | 8.23 Million | 5.89 Million | 3.2 Million | 2.79 Million | 4.66 Million |
| Research and Development Expenses | 19.36 Million | 18.93 Million | 22.55 Million | 21.98 Million | 28.15 Million | 29.03 Million |
| Other Expenses | 4.33 Million | 3.24 Million | 4.95 Million | 4.13 Million | 47 Thousand | -647 Thousand |
| Cost and Expenses | 30.96 Million | 30.41 Million | 33.4 Million | 29.32 Million | 30.99 Million | 33.04 Million |
| Operating Income | -29.69 Million | -27.83 Million | -28.12 Million | -24.93 Million | -30.29 Million | -33.04 Million |
| Interest Expense | 3.15 Million | 2.65 Million | 2.16 Million | 1.71 Million | 388 Thousand | 408 Thousand |
| Income Tax Expense | -1.69 Million | 5000.00 | 2000.00 | 2000.00 | 4000.00 | 408 Thousand |
| Earnings before Tax | -27.91 Million | -27.61 Million | -28.61 Million | -34.01 Million | -30.7 Million | -33.45 Million |
| Net Income | -26.22 Million | -27.62 Million | -28.61 Million | -34.01 Million | -30.71 Million | -33.45 Million |
| Earnings Per Share Basic | -0.54 | -0.60 | -0.63 | -0.97 | -1.08 | -1.37 |
| Earnings Per Share Diluted | -0.54 | -0.60 | -0.63 | -0.97 | -1.08 | -1.37 |
| Weighted Average Shares Outstanding | 48.31 Million | 46.33 Million | 45.15 Million | 35.12 Million | 28.38 Million | 24.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.31 Million | 46.33 Million | 45.15 Million | 35.12 Million | 28.38 Million | 24.46 Million |
| Gross Margin | 2.37 | 1.00 | 1.00 | 1.00 | 1.00 | 0.93 |
| EBIT Margin | -17.15 | -10.24 | -5.09 | -5.46 | -41.90 | -7.53 |
| Profit Margin | -20.69 | -10.70 | -5.42 | -7.74 | -43.87 | -7.70 |
| EBITDA | -21.73 Million | -26.44 Million | -26.83 Million | -34.13 Million | -29.31 Million | -32.73 Million |
| Earnings Before Tax Margin | -23.44 | -10.78 | -5.33 | -5.67 | -43.28 | -7.60 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 864 Thousand | 864 Thousand | 124 Thousand | 1.26 Million | 124 Thousand | 1.55 Million |
| Cost of Revenue | - | - | 1.32 Million | -1.73 Million | - | 192 Thousand |
| Gross Profit | 864 Thousand | 864 Thousand | -1.2 Million | 3 Million | 124 Thousand | 1.35 Million |
| Operating Expenses | 4.56 Million | 4.56 Million | 6.34 Million | 29.62 Million | 6.34 Million | 19.31 Million |
| Selling, General and Administrative Expenses | 1.42 Million | 1.42 Million | 2.74 Million | - | 2.74 Million | 7.69 Million |
| Research and Development Expenses | 3.14 Million | 3.14 Million | 3.68 Million | - | 3.68 Million | 11.62 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4.56 Million | 4.56 Million | 6.34 Million | 32.65 Million | 6.34 Million | 19.8 Million |
| Operating Income | -3.7 Million | -3.7 Million | -6.3 Million | -31.39 Million | -6.3 Million | -18.25 Million |
| Interest Expense | 466 Thousand | - | - | 3.15 Million | - | 1.34 Million |
| Income Tax Expense | 2500.00 | 2500.00 | 1000.00 | -1.69 Million | 1000.00 | -1.16 Million |
| Earnings before Tax | -2.92 Million | -2.92 Million | -7.13 Million | -27.91 Million | -7.13 Million | -13.12 Million |
| Net Income | -2.92 Million | -2.92 Million | -7.12 Million | -26.22 Million | -7.12 Million | -11.96 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | -0.14 | - | -0.14 | -0.26 |
| Earnings Per Share Diluted | -0.04 | -0.04 | -0.14 | - | -0.14 | -0.26 |
| Weighted Average Shares Outstanding | 82.75 Million | 82.75 Million | 50.55 Million | 48.31 Million | 50.55 Million | 46.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 82.74 Million | 82.74 Million | 50.55 Million | 48.31 Million | 50.55 Million | 46.07 Million |
| Gross Margin | 1.00 | 1.00 | -9.69 | 2.37 | 1.00 | 0.88 |
| EBIT Margin | -4.25 | -4.25 | -46.39 | - | -46.39 | -11.46 |
| Profit Margin | -3.38 | -3.38 | -57.49 | -20.69 | -57.49 | -7.72 |
| EBITDA | -3.67 Million | -3.67 Million | -5.75 Million | - | -5.75 Million | -17.76 Million |
| Earnings Before Tax Margin | -4.28 | -4.28 | -50.81 | -24.78 | -50.81 | -11.78 |
AMZN
MIMTF
603332
OP-PREFB
CHBAF
HAWKINCOOK